Sign in

CIK 0001773751

  • Large accelerated filer

Hims & Hers Health, Inc.

Sign in to watch
Ticker
HIMS
Exchange
NYSE
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-851-0195
Business address
2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
Former names
Oaktree Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,483,933
in 10 filings, $2.5M under 10b5-1 plans

Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-12 Dudum Andrew Chief Executive Officer Gift −1,954,379 0
2025-11-12 Dudum Andrew Chief Executive Officer Gift +1,954,379 3,004,071
2025-11-10 Boughton Soleil Chief Legal Officer Sale 10b5-1 −2,637 $42.53 $112K 155,856
2025-11-10 Dudum Andrew Chief Executive Officer Other disposition −260,000 2,423
2025-11-10 Dudum Andrew Chief Executive Officer Gift −1,049,692 0
2025-11-10 Dudum Andrew Chief Executive Officer Gift +1,049,692 1,049,692
2025-11-07 Dudum Andrew Chief Executive Officer Gift −262,423 0
2025-11-07 Dudum Andrew Chief Executive Officer Gift +262,423 262,423
2025-10-27 Boughton Soleil Chief Legal Officer Sale 10b5-1 −2,637 $50.10 $132K 158,493
2025-10-17 Okupe Oluyemi Chief Financial Officer Exercise or conversion 10b5-1 +7,785 $5.01 $39K 78,017
2025-10-17 Okupe Oluyemi Chief Financial Officer Exercise or conversion 10b5-1 +3,807 $11.53 $44K 81,824
2025-10-17 Okupe Oluyemi Chief Financial Officer Sale 10b5-1 −11,592 $57.13 $662K 70,232
2025-10-17 Okupe Oluyemi Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −7,785 174,380
2025-10-17 Okupe Oluyemi Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −3,807 56,169
2025-10-16 Dudum Andrew Chief Executive Officer Sale 10b5-1 −2,792 $62.65 $175K 92,523
2025-10-16 Dudum Andrew Chief Executive Officer Sale 10b5-1 −39,111 $62.70 $2.5M 55,947
2025-10-16 Dudum Andrew Chief Executive Officer Sale 10b5-1 −8,423 $63.46 $535K 47,524
2025-10-16 Dudum Andrew Chief Executive Officer Exercise or conversion 10b5-1 +17,001 $2.43 $41K 109,524
2025-10-16 Dudum Andrew Chief Executive Officer Sale 10b5-1 −17,001 $62.69 $1.1M 92,523
2025-10-16 Dudum Andrew Chief Executive Officer Exercise or conversion 10b5-1 +108,334 $2.43 $263K 200,857

Page 20 of 37 · 739 trades